Product Meta
Country of Origin
India
MEDICINE APPROVED BY
- Indian Medical Agency (IMA)
- Food and Drug Administration (FDA)
- Health Asia
DISEASE INDICATIONS
- European Medical Agency (EMA)
- Food and Drug Administration (FDA)
- Health India
We are experts in import regulations. Scroll below to download the import guide for your country.
FREQUENTLY ASKED QUESTIONS
Payments can be made by credit card or bank transfer. Payments are fully encrypted and secure. When paying by credit card, you can pay online once you have received your order confirmation. Please be aware that a 2.8% fee applies when paying by credit card.
Payments can be made by credit card or bank transfer. Payments are fully encrypted and secure. When paying by credit card, you can pay online once you have received your order confirmation. Please be aware that a 2.8% fee applies when paying by credit card.
Payments can be made by credit card or bank transfer. Payments are fully encrypted and secure. When paying by credit card, you can pay online once you have received your order confirmation. Please be aware that a 2.8% fee applies when paying by credit card.
Payments can be made by credit card or bank transfer. Payments are fully encrypted and secure. When paying by credit card, you can pay online once you have received your order confirmation. Please be aware that a 2.8% fee applies when paying by credit card.
Payments can be made by credit card or bank transfer. Payments are fully encrypted and secure. When paying by credit card, you can pay online once you have received your order confirmation. Please be aware that a 2.8% fee applies when paying by credit card.
Read Full FAQ
Price Estimated
WHERE CAN WE DELIVER?
- We have delivered medicines to more than 88 countries. Check if we have sent medicines to yours.
Our Patient Support Team will personally assist you along the way
Dr. Akshi Sudan
Patient Support Team Lead
Dr. Akshi Sudan
Patient Support Team Lead
- Registered independent intermediary.
View certificate.
- GDP compliant.
View certificate.
- Licensed wholesale distributor.
View certificate.
Read Full Product Details
🧬 Indication
Vanflyta is used for the treatment of:
Newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML) in adults.
It is used in combination with standard cytarabine and anthracycline induction and cytarabine consolidation, and then as maintenance monotherapy.
Approved by the US FDA in July 2023. This is a targeted therapy used only for AML with FLT3-ITD mutation
💊 Formulation & Strength
Dosage Form: Oral tablets
Available Strengths: 17.7 mg and 26.5 mg
🧪 Dosing Schedule
Induction (with chemo): 26.5 mg once daily on Days 8–21 of induction
Consolidation: Same dosing on Days 6–19 of each consolidation cycle
Maintenance: 26.5 mg orally once daily for up to 36 cycles
⚠️ Boxed Warning
QT Interval Prolongation
Vanflyta can prolong the QT interval, which may lead to life-threatening arrhythmias like Torsades de Pointes.
ECG monitoring and electrolyte correction are required before and during treatment.
🩺 Common Side Effects
Nausea, vomiting, diarrhea
Febrile neutropenia, anemia, thrombocytopenia
QT prolongation
Fatigue, rash, constipation
Decreased appetite
🚫 Contraindications & Precautions
Avoid in patients with baseline prolonged QTc interval or uncontrolled electrolyte imbalance
Monitor potassium, magnesium, calcium, and ECGs regularly
Caution with strong CYP3A inhibitors or inducers
Avoid grapefruit and Seville oranges
⚠️ Use in Pregnancy & Lactation
Not recommended in pregnancy
Avoid breastfeeding during and for 1 week after last dose
✅ Conclusion
Vanflyta (quizartinib) is a specialized FLT3-ITD targeted therapy for newly diagnosed AML patients, showing improved survival when combined with chemotherapy.
However, due to QT prolongation risks, close ECG and electrolyte monitoring is mandatory. It’s a promising addition for a specific AML subtype,
offering a personalized treatment approach.
This content has been reviewed by a Medical Doctor.
Four steps to access the medicines you need
Submit a request for a specific medicine, or a general request, and your Patient Support Manager will contact you within 24 hours. They will be there to support and guide you in anyway possible to help you get the medicine you need.
Since we help patients access medicines not available in their home country, our first step is to check that the medicine you need is not currently available in your home country. Next we will also verify that you have a prescription from a doctor in your home country for the medicine you need.
Once we have verified your prescription and medical details, our expert sourcing team will work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.
This content has been reviewed by a Medical Doctor.
